Finance

Lists
PRE:NASDAQ
Prenetics Global Ltd
25,44 US$
-0,74%
(-0,19) 1D
25,73 US$
+1,15% (+0,29)
After hours
Closed: 4 სექ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
25,63 US$
High
26,02 US$
Low
25,13 US$
Mkt. cap
436,13 მლნ.
Avg. vol.
225,71 ათ.
Volume
105,97 ათ.
52-wk high
27,24 US$
52-wk low
7,93 US$
EPS
-2,88 US$
Beta
0,38
Shares outstanding
15,56 მლნ.
No. of employees
98
Open
25,63 US$
High
26,02 US$
Low
25,13 US$
Mkt. cap
436,13 მლნ.
Avg. vol.
225,71 ათ.
Volume
105,97 ათ.
52-wk high
27,24 US$
52-wk low
7,93 US$
EPS
-2,88 US$
Beta
0,38
Shares outstanding
15,56 მლნ.
No. of employees
98
News stories
From web sources and news partners
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth care provider
Websiteprenetics.com
Analyst ratings
Based on 4 analysts giving stock ratings to PRE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current 25,44 US$
40,00 US$ (+57,23%)
Average
37,00 US$ (+45,44%)
Lowest
35,00 US$ (+37,58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeff Van Sinderen
B. Riley Securities
Buy
Initiated
37,00 US$
+45,4%
08/27/2026
Ryan Meyers
Lake Street
Buy
Reiterated
35,00 US$
+37,6%
08/19/2026
George Kelly
Roth MKM
Buy
Maintained
36,00 US$
+41,5%
08/19/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
40,00 US$
+57,2%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
23,56 მლნ.
36,56 მლნ.
35,95 მლნ.
46,49 მლნ.
Cost of goods sold
9,53 მლნ.
14,97 მლნ.
12,67 მლნ.
16,28 მლნ.
Cost of revenue
9,53 მლნ.
14,97 მლნ.
12,67 მლნ.
16,28 მლნ.
Research and development expenses
1,17 მლნ.
743,00 ათ.
1,44 მლნ.
757,00 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,41 მლნ.
34,13 მლნ.
31,55 მლნ.
51,36 მლნ.
Operating expense
20,19 მლნ.
35,17 მლნ.
32,15 მლნ.
51,18 მლნ.
Total operating expenses
29,72 მლნ.
50,14 მლნ.
44,82 მლნ.
67,47 მლნ.
Operating income
-6,16 მლნ.
-13,58 მლნ.
-8,87 მლნ.
-20,98 მლნ.
Other non operating income
96,00 ათ.
9,59 მლნ.
-17,86 მლნ.
9,28 მლნ.
EBT including unusual items
-6,78 მლნ.
-9,66 მლნ.
-27,31 მლნ.
-9,08 მლნ.
EBT excluding unusual items
-6,78 მლნ.
-3,87 მლნ.
-26,74 მლნ.
-11,71 მლნ.
Income tax expense
9,00 ათ.
38,00 ათ.
28,00 ათ.
5,00 ათ.
Effective tax rate
-0,13%
-0,39%
-0,10%
-0,06%
Other operating expenses
-395,00 ათ.
297,00 ათ.
-840,00 ათ.
-941,00 ათ.
Net income
-7,41 მლნ.
-7,50 მლნ.
-23,10 მლნ.
-8,98 მლნ.
Net profit margin
-31,45%
-20,52%
-64,26%
-19,32%
Earnings per share
-
-0,19
-
-0,52
Interest and investment income
-
1,20 მლნ.
-
-
Interest expense
-55,00 ათ.
-45,00 ათ.
-9,00 ათ.
-13,00 ათ.
Net interest expenses
-55,00 ათ.
1,15 მლნ.
-9,00 ათ.
-13,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,33 მლნ.
-13,34 მლნ.
-8,71 მლნ.
-20,80 მლნ.
Gain or loss from assets sale
-
-
-253,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები